You must log in to view this page.

INmune Bio Inc.

NASDAQ: INMB
Share price (8/15/25): $2.53
Market cap (8/15/25): $67.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities on exchange – amended

Ownership Filter

CVI Investments, Inc.

Praetorian PR LLC

Highbridge Capital Management LLC

CVI Investments, Inc.

Praetorian PR LLC

News Filter

Q2 2025 and Recent Corporate Highlights DN-TNF Platform Highlights (XPro™)

To Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference

To Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference

Announces Approximately $19 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Reports Key Findings From Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC